- Home
- BKH vs ADMA Comparison
BKH vs ADMA Comparison
Compare BKH & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKH
- ADMA
- Stock Information
- Founded
- BKH 1941
- ADMA 2004
- Country
- BKH United States
- ADMA United States
- Employees
- BKH N/A
- ADMA N/A
- Industry
- BKH Electric Utilities: Central
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BKH Utilities
- ADMA Health Care
- Exchange
- BKH Nasdaq
- ADMA Nasdaq
- Market Cap
- BKH 4.3B
- ADMA 5.1B
- IPO Year
- BKH N/A
- ADMA N/A
- Fundamental
- Price
- BKH $56.91
- ADMA $18.67
- Analyst Decision
- BKH Hold
- ADMA Strong Buy
- Analyst Count
- BKH 3
- ADMA 3
- Target Price
- BKH $66.00
- ADMA $27.67
- AVG Volume (30 Days)
- BKH 585.0K
- ADMA 3.5M
- Earning Date
- BKH 07-30-2025
- ADMA 08-07-2025
- Dividend Yield
- BKH 4.75%
- ADMA N/A
- EPS Growth
- BKH N/A
- ADMA N/A
- EPS
- BKH 3.95
- ADMA 0.84
- Revenue
- BKH $2,206,500,000.00
- ADMA $459,381,000.00
- Revenue This Year
- BKH $4.90
- ADMA $23.35
- Revenue Next Year
- BKH $3.27
- ADMA $27.67
- P/E Ratio
- BKH $14.39
- ADMA $21.87
- Revenue Growth
- BKH 3.28
- ADMA 62.23
- 52 Week Low
- BKH $53.22
- ADMA $10.21
- 52 Week High
- BKH $65.59
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- BKH 48.91
- ADMA 41.64
- Support Level
- BKH $55.50
- ADMA $17.67
- Resistance Level
- BKH $57.24
- ADMA $18.92
- Average True Range (ATR)
- BKH 0.82
- ADMA 0.77
- MACD
- BKH 0.13
- ADMA -0.05
- Stochastic Oscillator
- BKH 71.36
- ADMA 22.25
About BKH Black Hills Corporation
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.